ライフサイエンスコーパス: care for patients with

1 f the problems inherent in the treatment and care for patients with a chronic disease that might pers

2 The standard of care for patients with a positive (+) sentinel lymph nod

3 The inflation-adjusted cost of care for patients with a primary diagnosis of pemphigus

4 The total inflation-adjusted cost of care for patients with a primary inpatient diagnosis of

5 uld be used to improve access to neurologist care for patients with a range of chronic neurological d

6 Physicians caring for patients with AA should consider screening fo

7 sions about the appropriate level of medical care for patients with acute chest pain.

8 l admission on length of stay and quality of care for patients with acute decompensated heart failure

9 itive, this should provide an improvement in care for patients with acute infectious diarrheal diseas

10 lation with low tidal volumes is standard of care for patients with acute respiratory distress syndro

11 ing us closer to providing superb and timely care for patients with acute surgical conditions.

12 ive, this technology is available to centers caring for patients with acute liver failure and deserve

13 te care surgery is the growing difficulty in caring for patients with acute surgical conditions.

14 ality and coverage of appropriate palliative care for patients with advanced cancer in sub-Saharan Af

15 asingly necessary to deliver the standard of care for patients with advanced cancer.

16 General internists often care for patients with advanced cancer.

17 tive care teams provide secondary supportive care for patients with advanced cancer.

18 These deficiencies in care for patients with advanced CKD likely adversely inf

19 herapies have revolutionized the standard of care for patients with advanced disease.

20 re integrated model to provide comprehensive care for patients with advanced HIV disease and their fa

21 ABVD remains the standard of care for patients with advanced Hodgkin lymphoma.

22 s for hospital may improve satisfaction with care for patients with advanced knee arthritis.

23 e-agent chemotherapy remains the standard of care for patients with advanced NSCLC and poor PS.

24 Although gemcitabine remains the standard of care for patients with advanced pancreatic cancer, addit

25 trial, sorafenib has become the standard of care for patients with advanced unresectable hepatocellu

26 Already, the standard of care for patients with advanced-stage NSCLC is shifting

27 tems in these countries face many challenges caring for patients with advanced cancer: inadequate fun

28 g oncologists, intensivists, and specialists caring for patients with advanced cardiac, pulmonary, re

29 hether genotyping should be part of standard care for patients with age-related macular degeneration

30 tment with high-dose spironolactone to usual care for patients with AHF for 96 hours was well tolerat

31 The definition and practice of end-of-life care for patients with AIDS will continue to evolve as A

32 Care for patients with alcohol or drug dependence diagno

33 or alcohol dependence could improve clinical care for patients with alcohol use disorders.

34 n monitoring compliance with the standard of care for patients with ALS and may have resulted in grea

35 Anesthesiologists frequently care for patients with altered hemostasis and coagulatio

36 t for achieving high hospital performance in care for patients with AMI.

37 Challenges of diagnosing and caring for patients with amyloidosis include determinati

38 techniques is essential for all surgeons who care for patients with aneurysms.

39 ht some of the more controversial aspects of caring for patients with anorectal malformation and offe

40 In caring for patients with anorexia nervosa, the primary c

41 d to gain an understanding of the quality of care for patients with arthritis.

42 uthors' considerable lifetime experiences in caring for patients with ARVC.

43 chemoembolization (TACE) is the standard of care for patients with asymptomatic noninvasive multinod

44 importance of early diagnosis and supportive care for patients with ATN has emerged.

45 anticoagulation translate well into clinical care for patients with atrial fibrillation.

46 formed at tertiary care centers that provide care for patients with autoimmune blistering disease in

47 clonal antibody rituximab is the standard of care for patients with B-cell non-Hodgkin lymphoma (B-NH

48 ioral health care dollar spent on outpatient care for patients with bipolar disorder, $1.80 is spent

49 lization is superior to standard psychiatric care for patients with borderline personality disorder.

50 al hospitalization with standard psychiatric care for patients with borderline personality disorder.

51 re will need interdisciplinary structures of care for patients with brain tumours and structured proc

52 he provision of guideline-recommended cancer care for patients with breast cancer and CRC did not var

53 When discussing the transition to palliative care for patients with breast cancer, oncologists have t

54 alignant changes; therefore, the standard of care for patients with CAIS should remain gonadectomy af

55 Palliative care for patients with cancer in Africa currently receiv

56 P-I) in improving the quality of end-of-life care for patients with cancer in hospitals and for their

57 to inform and allow assessment of palliative care for patients with cancer is urgently needed.

58 ble-blind trial of a statin with standard-of-care for patients with cancer, specifically SCLC.

59 ng are important concerns for clinicians who care for patients with cancer.

60 effects of cancer treatment, and palliative care for patients with cancer.

61 exercise-oncology researchers who assess and care for patients with cancer.

62 ity of regularly reporting on the quality of care for patients with cancer.

63 for improving the processes and outcomes of care for patients with cancer.

64 are not well incorporated into the standard care for patients with cancer.

65 Many nephrologists caring for patients with cancer in the United States hav

66 o high-quality providers, particularly those caring for patients with cancer.

67 us, miRNA levels may aid in tailoring health care for patients with cardiac arrest.

68 Recommendations to improve end-of-life care for patients with cardiovascular disease include op

69 as an integral component of the continuum of care for patients with cardiovascular disease.

70 This statement addresses what the specialist caring for patients with cardiovascular diseases and str

71 ls pose an important problem to neurologists caring for patients with cerebellar disorders.

72 It is incumbent on physicians who care for patients with CHD to be mindful of the effects

73 edical providers within the medical home who care for patients with CHD.

74 n erythropoietin (rHuEPO) is the standard of care for patients with chemotherapy-related anemia.

75 cing all medical and surgical subspecialists caring for patients with chest diseases.

76 g survival and is now considered standard of care for patients with Child A cirrhosis and good perfor

77 ice should be a component of holistic health care for patients with chronic ill health.

78 With respect to care for patients with chronic illness, 41.8 percent pre

79 Caregiver burden may result from providing care for patients with chronic illness.

80 isease and (2) to provide direction to those caring for patients with chronic liver diseases regardin

81 its use had become the de facto standard of care for patients with chronically relapsing refractory

82 delines define the criteria and standards of care for patients with cirrhosis and ascites.

83 The current standard of care for patients with CNS metastases is whole-brain rad

84 oaches might reduce utilization of inpatient care for patients with coexisting depression and dementi

85 surance expansion may help improve access to care for patients with colorectal cancer.

86 Surgeons caring for patients with colorectal cancer in multiple r

87 l survey of surgeons and medical oncologists caring for patients with colorectal cancer regarding whe

88 na Supplement, invited us to reminisce about caring for patients with common retinal disorders before

89 cost scalable strategy for improving medical care for patients with comorbid medical and serious ment

90 tment, we are continuing to raise quality of care for patients with complicated biliary diseases.

91 four domains that involve the professionals caring for patients with congenital cardiac disease all

92 rdiovascular imaging plays a central role in caring for patients with congenital heart disease (CHD).

93 volving global organization of professionals caring for patients with congenital heart disease.

94 Costs of ICU and non-ICU respiratory care for patients with COPD are higher than costs of car

95 nagement has recently become the standard of care for patients with coronary heart disease.

96 rdiac rehabilitation (CR) is the standard of care for patients with coronary heart disease.

97 Caring for patients with coronary stents in the perioper

98 targeted therapies, and advance personalized care for patients with CRC.

99 potential to help individualize and improve care for patients with CRPC.

100 The quality of care for patients with CVD is suboptimal.

101 ough previous studies suggest that access to care for patients with cystic fibrosis (CF) does not var

102 tion aiming to provide optimal treatment and care for patients with dementia and support caregivers u

103 End-of-life care for patients with dementia was extremely demanding

104 ed to substantial improvements in quality of care for patients with dementia.

105 isualizing geographic access barriers to eye care for patients with diabetes and may help to identify

106 pping for visualizing access barriers to eye care for patients with diabetes.

107 to assess variation in the use of intensive care for patients with diabetic ketoacidosis, a common c

108 ents could help signal whether variations in care for patients with different coverage forms are evol

109 ed availability of neurologists and improves care for patients with difficulty traveling owing to neu

110 support the early integration of palliative care for patients with diseases other than cancer and br

111 5-FU regimens, which are the standard of care for patients with Dukes' C disease, did not affect

112 aid in the choice of appropriate supportive care for patients with early-stage breast cancer.

113 many hospitals designated specific areas to care for patients with Ebola and other highly infectious

114 tals in the United States can safely provide care for patients with Ebola virus disease.

115 Health care personnel (HCP) caring for patients with Ebola virus disease (EVD) are a

116 have the potential to become the standard of care for patients with end-stage intestinal failure.

117 Liver transplantation is the standard of care for patients with end-stage liver disease.

118 lly recognized as the best current option in care for patients with end-stage renal disease, has show

119 Renal transplantation is the standard of care for patients with end-stage renal disease.

120 ess through self-awareness in the setting of caring for patients with end-stage illness.

121 ransplantation therapies have revolutionized care for patients with endstage organ (kidney, liver, he

122 rapy may be cost-effective relative to usual care for patients with enduring nonpsychotic symptoms wh

123 Primary care physicians often care for patients with epilepsy and therefore should be

124 ss the need for HCP to be prepared to safely care for patients with EVD and other high-consequence em

125 ng viral hemorrhagic fever, has received and cared for patients with EVD since the beginning of the o

126 Caring for patients with EVD placed substantial demands

127 It is important for healthcare providers who care for patients with frontotemporal dementia to recogn

128 as a novel means to advance the standard of care for patients with gastrointestinal cancers.

129 ate common clinical questions encountered in caring for patients with GERD, especially as they relate

130 Cataract and retinal eye care for patients with glaucoma substantially exceeded t

131 The total cost of nonglaucoma eye care for patients with glaucoma was 67% higher than thei

132 %), urban (99%), academic centers (59%) that cared for patients with greater comorbidities (P < .001)

133 interferon, and ribavirin is the standard of care for patients with HCV genotype 1 infection.

134 , bridging existing gaps in the continuum of care for patients with HCV infection.

135 This review of the current standard of care for patients with head and neck cancer aims to assi

136 epresented other organizations whose members care for patients with healthcare-associated ventriculit

137 variation in the delivery of evidence-based care for patients with heart failure (HF), but there is

138 patient-reported outcome measures in routine care for patients with heart failure (HF), how best to i

139 important component of improving quality of care for patients with heart failure and reduced ejectio

140 rements have clearly revolutionized clinical care for patients with heart failure, but further resear

141 g the incidence, prevalence and processes of care for patients with heart failure.

142 Clinicians who care for patients with hematologic malignancies and apla

143 iral agents (DAAs) represent the standard of care for patients with hepatitis C virus (HCV) infection

144 Trastuzumab is the foundation of care for patients with HER2-positive BC.

145 er support the value of GTWG-HF in improving care for patients with HF.

146 Demethylating agents are the standard of care for patients with higher risk MDS and the only agen

147 The concept of containment care for patients with highly hazardous infectious disea

148 antiretroviral therapy (cART) is standard of care for patients with HIV diagnosed with Kaposi's sarco

149 Many clinicians who care for patients with HIV infection are dissatisfied wi

150 ve raised new concerns about how to optimize care for patients with HIV infection.

151 Strategies to ensure optimal care for patients with HIV requires identifying the caus

152 Autologous HCT is now the standard of care for patients with HIV-related lymphomas who otherwi

153 system and over time, to deliver high-value care for patients with HIV/AIDS and cooccurring conditio

154 he false dichotomy of curative vs palliative care for patients with HIV/AIDS must be supplanted by a

155 less research attention than does palliative care for patients with HIV/AIDS, but in view of projecte

156 "curative" and symptom-specific "palliative" care for patients with HIV/AIDS.

157 cts can substantively change the standard of care for patients with HIV/AIDS.

158 Within a group of physicians caring for patients with HIV disease, the acceptance of

159 ree or more drugs has become the standard of care for patients with human immunodeficiency virus (HIV

160 tasks relevant to their disciplines, such as caring for patients with human immunodeficiency virus/ac

161 comes remains a key challenge for clinicians caring for patients with hypertension.

162 the gastroenterologists and other clinicians caring for patients with IBD to understand safety data r

163 the provision of state-of-the-art palliative care for patients with incurable cancer.

164 given the difficulty of defining appropriate care for patients with individual preferences and needs;

165 chemoembolisation (TACE) is the standard of care for patients with intermediate stage hepatocellular

166 sampling is now accepted as the standard of care for patients with intermediate thickness primary me

167 Surgery has become the standard of care for patients with intractable temporal lobe epileps

168 ntextualise the recommendation for providers caring for patients with IPF.

169 Although the current standard of care for patients with JMML relies on allogeneic hematop

170 Physicians likely to care for patients with JRA were made aware of the regist

171 ses has been made available to the clinician caring for patients with kidney stones and to the scient

172 atients in a large urban safety-net hospital caring for patients with limited access to medical care.

173 Physicians often find themselves caring for patients with limited English proficiency in

174 The standard of care for patients with localized, resectable retroperito

175 Neoadjuvant chemotherapy is the standard of care for patients with locally advanced breast cancer an

176 ealthy lifestyle counseling in their routine care for patients with LUTS.

177 scopic therapy should become the standard of care for patients with mAC.

178 Providing high quality nursing care for patients with malignancies is complex and drive

179 Trabeculectomy is the surgical standard of care for patients with medically refractory glaucoma.

180 fic use of imaging modalities for clinicians caring for patients with melanoma is presented.

181 taxel and prednisone remains the standard of care for patients with metastatic castration-resistant p

182 , which are now both part of the standard of care for patients with metastatic castration-resistant p

183 A kinase inhibitor, imatinib, is standard of care for patients with metastatic GIST.

184 nt with doxorubicin is a present standard of care for patients with metastatic soft-tissue sarcoma an

185 A serosurvey of 48 HWs who cared for patients with MHF was performed.

186 Multidisciplinary care for patients with MIBC and metastatic bladder cance

187 ho work within agreed guidelines can provide care for patients with minor injuries that is equal or i

188 Intravenous rtPA remains the standard of care for patients with moderate to severe neurological d

189 rphea in the near future will provide better care for patients with morphea and understanding its pat

190 ists, and other healthcare professionals who care for patients with native vertebral osteomyelitis (N

191 Care for patients with necrotizing soft tissue infection

192 for prompt diagnosis and to provide optimum care for patients with neurofibromatosis type 1, clinici

193 logy is vital to delivering optimal clinical care for patients with neurological disease regardless o

194 ng with radiation has become the standard of care for patients with newly diagnosed glioblastoma.

195 maintenance temozolomide is the standard of care for patients with newly diagnosed glioblastoma.

196 collaborative to improve standardization of care for patients with newly diagnosed POAG.

197 elines suggest increased responsibilities in caring for patients with newly found genetic cardiovascu

198 and mortality that are useful to clinicians caring for patients with NF1.

199 In many low-income countries, care for patients with non-communicable diseases (NCDs)

200 health care system would facilitate improved care for patients with non-insulin-dependent diabetes me

201 The current standard of care for patients with non-ST-elevation acute coronary s

202 IPSS risk was compared with best supportive care for patients with nonanemic low/intermediate-1 IPSS

203 Improved care for patients with obesity will need alignment of th

204 een growing interest in ambulatory models of care for patients with obstructive sleep apnea.

205 is used to measure the quality of systems of care for patients with out-of-hospital cardiac arrest.

206 he cost of care and improving the quality of care for patients with PCI.

207 ns to peanut could significantly improve the care for patients with peanut allergy.

208 s are relevant for all health care providers caring for patients with pediatric psoriasis, including

209 cost-effectiveness of stepped collaborative care for patients with persistent depressive symptoms af

210 o be developed and have potential to improve care for patients with pituitary tumors.

211 ortunity to help determine stratification of care for patients with POFP.

212 with critical care clinicians about goals of care for patients with poor postoperative outcomes.

213 that the nurses in the ICU have expertise in caring for patients with poor respiratory function.

214 respirators, eye protection, and gowns when caring for patients with potentially communicable diseas

215 Physicians caring for patients with primary immunodeficiency diseas

216 important to consider for those managing and caring for patients with progressive supranuclear palsy.

217 ists, and other healthcare professionals who care for patients with prosthetic joint infection (PJI).

218 receptor blocker therapy is the standard of care for patients with proteinuric kidney diseases, but

219 ence is therefore a key challenge to quality care for patients with psychiatric disorders.

220 iency of discovery to improve the quality of care for patients with pulmonary nodules.

221 gist care is not more costly than generalist care for patients with RA.

222 o enable some level of evidence-based health care for patients with rare cancers.

223 ous stem-cell transplantation is standard of care for patients with relapsed or primary refractory Ho

224 a poor prognosis and no accepted standard of care for patients with relapsed or refractory disease.

225 epdown beds provide an intermediate level of care for patients with requirements somewhere between th

226 The primary goal of care for patients with resectable and borderline-resecta

227 d fluorouracil chemotherapy as a standard of care for patients with resectable esophagogastric cancer

228 ve chemotherapy and surgery is a standard of care for patients with resectable oesophagogastric adeno

229 the use of NPPV as routine standard medical care for patients with respiratory failure outside of co

230 biomarkers promises to enhance the clinical care for patients with rheumatoid arthritis (RA) and oth

231 rheumatologist care compared with generalist care for patients with rheumatoid arthritis (RA).

232 ial treatment program to routine psychiatric care for patients with schizophrenia and substance use d

233 ment and had all items in a 3-hour bundle of care for patients with sepsis (i.e., blood cultures, bro

234 real-world conditions, to improve quality of care for patients with serious mental illness and cardio

235 ell as an approach to care by all clinicians caring for patients with serious and complex illness.

236 ogy clinicians should be logical partners in caring for patients with serious cancers for which sympt

237 d review to assist critical care physicians' care for patients with severe acute lung injury and acut

238 dy approved as add-on therapy to standard of care for patients with severe eosinophilic asthma, has b

239 benefit associated with advanced prehospital care for patients with severe head injury.

240 Physicians caring for patients with severe HIV-related PCP should b

241 Whether hospitals with more experience caring for patients with severe sepsis also have improve

242 Clinicians caring for patients with severe sepsis or septic shock s

243 survey to understand attitudes of physicians caring for patients with severe traumatic brain injury t

244 ialysis catheters; specialized nursing teams caring for patients with short-term peripheral venous ca

245 Physicians caring for patients with sickle cell disease should be a

246 spitals in which there is more experience in caring for patients with SLE.

247 opic techniques are changing the paradigm of care for patients with small bowel bleeding.

248 ical technology have changed the standard of care for patients with spinal muscular atrophy.

249 ore intensive regional approach to emergency care for patients with ST-segment-elevation myocardial i

250 t well known but is important for clinicians caring for patients with stable COPD.

251 effects, should be considered as standard of care for patients with stage IA NLPHL.

252 Improvements in access to timely care for patients with STEMI will require a multifaceted

253 ealthcare teams in the process of organizing care for patients with STEMI.

254 and as an important prognostic measure when caring for patients with STEMI.

255 h few data available regarding management of care for patients with such conditions.

256 re staffs are increasingly likely to provide care for patients with such disease.

257 oke center (CSC) may improve the delivery of care for patients with suspected emergent large-vessel o

258 correlates of the intermediate-term cost of caring for patients with suspected coronary artery disea

259 ow generally accepted as the new standard of care for patients with symptomatic aortic stenosis who a

260 promise to provide specialized and efficient care for patients with syncope.

261 atment option that is superior to supportive care for patients with the MDS subtypes and specific ent

262 e reached, the improvement in the quality of care for patients with these conditions slowed, and the

263 lace to address deactivation may improve the care for patients with these devices.

264 umatologists and primary care physicians who care for patients with these disorders.

265 ther study to better understand and optimize care for patients with this complex disease.

266 ghted the lack of good studies of palliative care for patients with this disease.

267 support trimodality therapy as a standard of care for patients with this disease.

268 cal-pathological associations should advance care for patients with this important class of neurodege

269 ans are often at the front-lines in terms of caring for patients with this chief complaint.

270 were released to help guide the clinician in caring for patients with this ever more prevalent and co

271 therapy should be considered the standard of care for patients with TRIL who have received prior syst

272 lar risk, the net value of changes in health care for patients with type 2 diabetes was $10,911 per p

273 nce for this guideline is all clinicians who care for patients with type 2 diabetes.